G. Soardo

Red rice (Monakoline K) effects on oxidative stress parameters and biomarkers of steatosis in mild hypercholesterolemic NAFLD patients
20230 citationsauthor #10
Hepatic encephalopathy increases the risk for mortality and hospital readmission in decompensated cirrhotic patients: a prospective multicenter study
202320 citationsauthor #22
A prospective multicenter study to examine the impact of acquired and genetic predictors on Hepatocellular carcinoma risk in patients with advanced NAFLD: first report
20230 citationsauthor #10
Alcohol Intake and Arterial Hypertension: Retelling of a Multifaceted Story
202324 citationsauthor #6
Effects of Monacolin K in Nondiabetic Patients with NAFLD: A Pilot Study
20235 citationsauthor #11
Clinical exome sequencing for diagnosing severe cryptogenic liver disease in adults: A case series
202216 citationsauthor #8
Increased burden of inherited IRF3 rare genetic variants in Europeans with severe Non-alcoholic fatty liver diease
20220 citationsauthor #13
Association of non-alcoholic fatty liver disease with left ventricular changes in treatment-naive patients with uncomplicated hypertension
202215 citationsauthor #7
Increased burden of inherited IRF3 rare genetic variants in Europeans with severe NAFLD
20220 citationsauthor #13
Rare ATG7 genetic variants predispose patients to severe fatty liver disease.
202269 citationsauthor #25
Hepatoportal Sclerosis in patient with Systemic Sclerosis and Sjögren’s Syndrome: a rare association
20210 citationsauthor #1
Nonalcoholic fatty liver and left ventricular remodelling: now the prospective evidence.
20211 citationsauthor #2
The rs599839 A>G Variant Disentangles Cardiovascular Risk and Hepatocellular Carcinoma in NAFLD Patients
202120 citationsauthor #9
Whole exome sequencing for the diagnosis of rare genetic conditions in patients with unexplained liver disease and complex clinical presentation
20211 citationsauthor #7
OC-08Rare ATG7 genetic variants predispose to severe fatty liver disease
20210 citationsauthor #21
Rare Atg7 Genetic Variants Predispose to Severe Fatty Liver Disease
20210 citationsauthor #21
Obesity Modifies the Performance of Fibrosis Biomarkers in Nonalcoholic Fatty Liver Disease
202144 citationsauthor #12
Rare and common ATG7 variants predispose to severe fatty liver disease
20210 citationsauthor #17
A polygenic risk score for progressive non-alcoholic fatty liver disease risk stratification
20202 citationsauthor #17
Noninvasive risk stratification in nonalcoholic fatty liver disease: a polygenic risk score
20200 citationsauthor #17
Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores
2020277 citationsauthor #26
Monomorphic Epitheliotropic Intestinal T Cell Lymphoma of the Appendix: a Case Report and Review of Literature
20208 citationsauthor #1
Neurotensin up-regulation is associated with advanced fibrosis and hepatocellular carcinoma in patients with MAFLD.
202015 citationsauthor #6
FRI-333-ATG7 genetic variant and defective autophagy: A novel risk factor for non-alcoholic fatty liver disease progression in patients with type 2 diabetes mellitus
20190 citationsauthor #12
Sustained virologic response to direct-acting antiviral agents predicts better outcomes in hepatitis C virus-infected patients: A retrospective study
201920 citationsauthor #9
Risk of liver disease in first-degree relatives of patients with advanced NAFLD: initial data from an Italian cohort study
20190 citationsauthor #7
Rare Pathogenic Variants Predispose to Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease
2019107 citationsauthor #13
Hepatocellular metastasis recurrence in liver transplant after treatment with direct antiviral agents
20191 citationsauthor #6
ATG7 genetic variant and defective autophagy: a novel risk factor for non-alcoholic fatty liver disease progression in patients with type 2 diabetes mellitus
20190 citationsauthor #11
P.09.24 ROLE OF SERPINB3 AND FIBROBLAST GROWTH FACTOR-21 IN THE PROGRESSION FROM NAFLD TO NASH
20180 citationsauthor #1
Integrative analysis of NGS data highlight a genetic variant in ATG7 gene as a novel risk factor for nonalcoholic fatty liver disease progression
20180 citationsauthor #6
Role of rare pathogenic mutations in the development of hepatocellular carcinoma in patients with nonalcoholic fatty liver disease
20180 citationsauthor #13
Functional characterization of a novel genetic variant predisposing to hepatocellular carcinoma development in nonalcoholic fatty liver disease
20180 citationsauthor #6
OC.04.2 NON ADHERENCE TO AASLD – EASL GUIDELINES FOR THE MANAGEMENT OF HEPATOCELLULAR CARCINOMA DOES NOT TRANSLATE INTO WORSE OUTCOMES
20180 citationsauthor #12
Protein phosphatase 1 regulatory subunit 3B gene variation protects against hepatic fat accumulation and fibrosis in individuals at high risk of nonalcoholic fatty liver disease
201840 citationsauthor #14
A simple in silico strategy identifies candidate biomarkers for the diagnosis of liver fibrosis in morbidly obese subjects
20189 citationsauthor #10
Role of SERPINB3 like serological and molecular biomarker into NASH development and progression
20180 citationsauthor #11
P.09.4 EVALUATION OF PROGNOSTIC FACTORS OF OVERALL SURVIVAL AND PROGRESSION-FREE SURVIVAL IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC)
20180 citationsauthor #13
MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals
20172 citationsauthor #24
MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals
2017240 citationsauthor #24
Telomerase reverse transcriptase germline mutations and hepatocellular carcinoma in patients with nonalcoholic fatty liver disease
201748 citationsauthor #20
NOVEL BIOMARKERS FOR THE DIAGNOSIS OF LIVER FIBROSIS IN A HIGHLY RISK NAFLD COHORT in IFSO 2017 22(nd) World Congress
20172 citationsauthor #11
Omega-3 Polyunsaturated Fatty Acids in the Treatment of Non-Alcoholic FattyLiver Disease: Are They So Good?
20174 citationsauthor #2
Real life of DAAs (direct antiviral agents) for HCV infection in Friuli Venezia Giulia: Who, why, what, how did we treat?
20160 citationsauthor #4
Complete Remission of Unresectable Hepatocellular Carcinoma After Combined Sorafenib and Adjuvant Yttrium-90 Radioembolization
20165 citationsauthor #5
Immunologic and Pharmacologic Aspects in an Elderly Recipient of Liver Transplant With Pulmonary Aspergillosis and Multiple Comorbidities.
20161 citationsauthor #7
Hepatitis C patients with any degree of portal hypertension are at risk to develop serious adverse effect to direct-acting antiviral therapies
20160 citationsauthor #5
MBOAT7 locus rs641738 variant predisposes to hepatocellular carcinoma in nonalcoholic fatty liver
20162 citationsauthor #17
In Silico Identification and in Vivo Validation of Non-Invasive Biomarkers for Liver Fibrosis
20160 citationsauthor #7
Moderate Alcohol Consumption Is Associated With Left Ventricular Diastolic Dysfunction in Nonalcoholic Hypertensive Patients
201629 citationsauthor #6
Clinical patterns of hepatocellular carcinoma (HCC) in non alcoholic fatty liver disease (NAFLD): a multicenter case-control study
20152 citationsauthor #38
O071 : Telomerase reverse transcriptase mutations are associated with hepatocellular carcinoma in nash
20151 citationsauthor #15
Acetaminophen-induced liver injury in a woman with febrile flare of systemic lupus erythematosus.
20142 citationsauthor #3
Intra-abdominal penetration and pharmacodynamic exposure to fluconazole in three liver transplant patients with deep-seated candidiasis.
201426 citationsauthor #6
Spleen stiffness measurement by ARFI strongly predict the oesophageal varices stage and bleeding probability
20140 citationsauthor #9
INCREASED SERUM PHOSPHOLIPASE A 2 ACTIVITY IN ADVANCED CHRONIC LIVER DISEASE AS AN EXPRESSION OF THE ACUTE PHASE
20140 citationsauthor #2
Enrichment in novel rare coding variants of Telomerase gene in hepatocellular carcinoma patients with NASH related cirrhosis
20140 citationsauthor #6
Chapter 10 Signs and Symptoms
20130 citationsauthor #4
PNPLA3 I148M Polymorphism, Clinical Presentation, and Survival in Patients with Hepatocellular Carcinoma
201358 citationsauthor #3
Surgical Treatment Strategies and Prognosis of Hepatocellular Carcinoma
20131 citationsauthor #6
T-22 Carotid intima-media thickness, endothelial lipase and hepatic lipase are altered in subjects with non alcoholic fatty liver disease (NAFLD)
20130 citationsauthor #9
CS.01.3 THE EMERGING IMPACT OF HCC-NAFLD IN ITALY
20120 citationsauthor #12
OC-26 The emerging impact of HCC-NAFLD in Italy
20121 citationsauthor #12
647 TISSUE DOPPLER IMAGING ANALISYS IMPROVES THE SENSBILITY AND SPECICIFITY IN THE DIAGNOSIS OF DIASTOLIC DYSFUNCTION IN CIRRHOTIC CARDIOMYOPATHY
20120 citationsauthor #10
T-34 Effect of statin therapy vs diet in hypercholesterolemic patients affected by nonalcoholic steatohepatitis (NASH)
20122 citationsauthor #11
315 I148M PNPLA3 POLYMORPHISM IS ASSOCIATED WITH CLINICAL FEATURES IN PATIENTS WITH HEPATOCELLULAR CARCINOMA
20124 citationsauthor #3
F-9 The I148M PNPLA3 polymorphism is associated with the clinical presentation and prognosis of hepatocellular carcinoma
20120 citationsauthor #3
T-20 Tissue Doppler imaging analysis, a new method for the diagnosis of diastolic dysfunction in cirrhotic cardiomyopathy
20120 citationsauthor #10
595 BENEFICIAL EFFECT OF N-ACETYL-CYSTEINE ON HEPATIC ENCEPHALOPATHY: “IN VIVO” AND “IN VITRO” STUDY
20110 citationsauthor #10
T-22 Effect of dietary intervention and weight loss on circulating and hepatic expression of fibroblast growth factor-21 in non alcoholic steatohepatitis
20110 citationsauthor #10
Oxidative Stress Is Activated by Free Fatty Acids in Cultured Human Hepatocytes
201159 citationsauthor #1
F.N.30 TREATMENT OF CHRONIC HEPATITIS C WITH PEG-INF-α PLUS RIBAVIRIN DOESN'T ALTER FLUOXETINE DISPOSAL
20100 citationsauthor #1
Fluoxetine Disposition in Patients with Chronic Hepatitis C Treated with Interferon-α
20104 citationsauthor #2
Safety of conversion from twice-daily tacrolimus (Prograf) to once-daily prolonged-release tacrolimus (Advagraf) in stable liver transplant recipients.
201023 citationsauthor #9
986 INTRAHEPATIC CHOLESTATIS OF PREGNANCY: A “IN VIVO” MODEL OF THE HEPATIC CLEARANCE OF ADIPONECTIN
20100 citationsauthor #1
7 REDUCED FGF-21 EXPRESSION IN LIVER OF PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE
20100 citationsauthor #1
ENDOTHELIAL FUNCTION IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE: PP.6.241
20100 citationsauthor #7
745 BENEFICIAL EFFECT OF N-ACETYLCYSTEINE AND GLUTATHIONE ON AMMONIA-INDUCED GLUTAMATE ACCUMULATION IN ASTROCYTE CELL CULTURE
20090 citationsauthor #8
Hepatocellular carcinoma in the elderly
20090 citationsauthor #10
Hepatocellular carcinoma in the elderly
20090 citationsauthor #10
Free fatty acid induce oxidative stress in HEPG2-cell. Protective role of anti-oxidant substances and adiponectin
20080 citationsauthor #1
Elevated adiponectin levels in heavy drinkers are related to liver disease severity: Effects of alcohol withdrawal
20080 citationsauthor #10
Metabolic Aspects and Mechanisms
20080 citationsauthor #8
9.3 Non-alcoholic Fatty Liver Disease, Adiponectin and Insulin-Resistance In Dipper And Non-Dipper Essential Hypertensive Patients
20080 citationsauthor #8
Effects of Antihypertensive Drugs on Alcohol-Induced Functional Responses of Cultured Human Endothelial Cells
200816 citationsauthor #1
Nonalcoholic fatty liver disease, adiponectin and insulin resistance in dipper and nondipper essential hypertensive patients
200841 citationsauthor #8
970 FREE FATTY ACID INDUCE OXIDATIVE STRESS IN HEPG2-CELL. PROTECTIVE ROLE OF ANTI-OXIDANT SUBSTANCES AND ADIPONECTIN
20080 citationsauthor #1
Hepatobiliary phospholipid transporter ABCB4, MDR3 gene variants in a large cohort of Italian women with intrahepatic cholestasis of pregnancy.
200878 citationsauthor #4
[302] MDR3 MUTATIONS IN A LARGE COHORT OF ITALIAN WOMEN WITH INTRAHEPATIC CHOLESTASIS OF PREGNANCY (ICP)
20070 citationsauthor #3
[759] ADIPONECTIN PROTECTS AGAINST FATTY ACIDS-INDUCED IMPAIRMENT OF ENDOTHELIAL FUNCTION IN VITRO. IMPLICATIONS FOR VASCULAR DYSFUNCTION IN NON-ALCOHOLIC FATTY LIVER DISEASE
20070 citationsauthor #1
Increased serum resistin in nonalcoholic fatty liver disease is related to liver disease severity and not to insulin resistance.
2006200 citationsauthor #2
Intrahepatic cholestasis of pregnancy: three novel MDR3 gene mutations
200668 citationsauthor #4
Rituximab treatment for glomerulonephritis in HCV-associated mixed cryoglobulinaemia: efficacy and safety in the absence of steroids.
2006172 citationsauthor #2
Effects of alcohol withdrawal on blood pressure in hypertensive heavy drinkers
200623 citationsauthor #1
Alcohol-induced endothelial changes are associated with oxidative stress and are rapidly reversed after withdrawal.
200552 citationsauthor #1
The Emergent Cardiovascular Risk Factors and Organ Damage in Arterial Hypertension
20050 citationsauthor #7
Elevated serum CA 19-9 in hepatic actinomycosis
200510 citationsauthor #1
Value of serum C-reactive protein measurement in the detection of hepatocellular carcinoma superimposed on liver cirrhosis
20057 citationsauthor #3
Henoch-Schönlein purpura in a patient with diabetic nephropathy and vascular complications.
20052 citationsauthor #4
Alcohol-Induced Endothelial Changes are Mediated by an Increased Oxidative Stress and are Rapidly Reversed after Withdrawal: 6.13
20050 citationsauthor #1

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT